Intravitreal adalimumab for refractory uveitis-related macular edema

Ophthalmology

Volumn 117, Issue 8, 2010, Pages 1612-1616

  Androudi, Sofia ^a,b   Tsironi, Evangelia ^b   Kalogeropoulos, Christos ^c   Theodoridou, Athina ^a   Brazitikos, Periklis ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b UNIVERSITY OF THESSALY   (Greece)

^c UNIVERSITY OF IOANNINA   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; STEROID;

ADULT; ADVERSE DRUG REACTION; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG DOSE ESCALATION; DRUG TREATMENT FAILURE; FEMALE; FOLLOW UP; HUMAN; INTERVENTION STUDY; MALE; OBSERVATION; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETINA MACULA CYSTOID EDEMA; STATISTICAL SIGNIFICANCE; UVEITIS; VISUAL ACUITY;

ADULT; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; INJECTIONS; MACULAR EDEMA; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RETINA; RETREATMENT; TOMOGRAPHY, OPTICAL COHERENCE; TUMOR NECROSIS FACTOR-ALPHA; UVEITIS; VISUAL ACUITY; VITREOUS BODY; YOUNG ADULT;

EID: 77955471795     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2009.12.011     Document Type: Article

References (23)

1. N. Okhravi, and S. Lightman Cystoid macular edema in uveitis Ocul Immunol Inflamm 11 2003 29 38
2. R. Nussenblatt Treating intraocular inflammatory disease in the 21st century Arch Ophthalmol 123 2005 1000 1001
3. D.C. Gritz, and I.G. Wong Incidence and prevalence of uveitis in Northern California: the Northern California Epidemiology of Uveitis Study Ophthalmology 111 2004 491 500
4. R.B. Nussenblatt The natural history of uveitis Int Ophthalmol 14 1990 303 308
5. C.W. Lardenoye, B. van Kooij, and A. Rothova Impact of macular edema on visual acuity in uveitis Ophthalmology 113 2006 1446 1449
6. H.F. Fine, J. Baffi, and G.F. Reed, et al. Aqueous humor and plasma vascular endothelial growth factor in uveitis-associated cystoid macular edema Am J Ophthalmol 132 2001 794 796
7. G. Freeman, Matos, and C.E. Pavesio Cystoid macular oedema in uveitis: an unsolved problem Eye (Lond) 15 2001 12 17
8. R.B. Nussenblatt Macular alterations secondary to intraocular inflammatory disease Ophthalmology 93 1986 984 988
9. S. Androudi, E. Letko, and M. Meniconi, et al. Safety and efficacy of intravitreal triamcinolone injection for uveitic macular edema Ocul Immunol Inflamm 13 2005 205 212
10. M. Lafranco Dafflon, V.T. Tran, Y. Guex-Crosier, and C.P. Herbort Posterior sub-Tenon's steroid injections for the treatment of posterior ocular inflammation: indications, efficacy and side effects Graefes Arch Clin Exp Ophthalmol 237 1999 289 295
11. A.B. Thach, P.U. Dugel, and R.J. Flindall, et al. A comparison of retrobulbar versus sub-Tenon's corticosteroid therapy for cystoid macular edema refractory to topical medications Ophthalmology 104 1997 2003 2008
12. M. Cordero Coma, L. Sobrin, and S. Onal, et al. Intravitreal bevacizumab for treatment of uveitic macular edema Ophthalmology 114 2007 1574 1579
13. F. Mackensen, C. Heinz, M.D. Becker, and A. Heiligenhaus Intravitreal bevacizumab (Avastin) as a treatment for refractory macular edema in patients with uveitis: a pilot study Retina 28 2008 41 45
14. N.R. Acharya, K.C. Hong, and S.M. Lee Ranibizumab for refractory uveitis-related macular edema Am J Ophthalmol 148 2009 303 309
15. H. Kok, C. Lau, and N. Maycock, et al. Outcome of intravitreal triamcinolone in uveitis Ophthalmology 112 2005 1916 1921
16. B. van Kooij, A. Rothova, and P. de Vries The pros and cons of intravitreal triamcinolone injections for uveitis and inflammatory cystoid macular edema Ocul Immunol Inflamm 14 2006 73 85
17. M. Zierhut, H.J. Thiel, and T. Schlote Treatment of uveitic macular edema with acetazolamide Doc Ophthalmol 97 1999 409 413
18. P.U. Dugel, N.A. Rao, and S. Ozler, et al. Pars plana vitrectomy for intraocular inflammation-related cystoid macular edema unresponsive to corticosteroids: a preliminary study Ophthalmology 99 1992 1535 1541
19. P.G. Theodossiadis, V.S. Liarakos, and P.P. Sfikakis, et al. Intravitreal administration of the anti-tumor necrosis factor infliximab for neovascular age-related macular degeneration Am J Ophthalmol 147 2009 825 830
20. R.P. Manzano, G.A. Peyman, and P.E. Carvounis, et al. Ocular toxicity of intravitreal adalimumab (Humira) in the rabbit Graefes Arch Clin Exp Ophthalmol 246 2008 907 911
21. M. Tsilimbaris, M.F. Diakonis, and I. Naoumidi, et al. Evaluation of potential retinal toxicity of adalimumab (Humira) Graefes Arch Clin Exp Ophthalmol 247 2009 1119 1125
22. M.W. Wiedmann, J. Mössner, C. Baerwald, and M. Pierer TNF alpha inhibition as treatment modality for certain rheumatologic and gastrointestinal diseases Endocr Metab Immune Disord Drug Targets 9 2009 295 314
23. D.A. Jabs, R.B. Nussenblatt, and J.T. Rosenbaum Standardization of uveitis nomenclature for reporting clinical data: results of the First International Workshop Am J Ophthalmol 140 2005 509 516